Skip to main content

Syneos Health, Inc.

SYNHDelisted
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001610950

Syneos Health, Inc. was delisted in 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.35B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Syneos Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Syneos Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Syneos Health, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Klitgaard William EDirector0Sep 28, 20230
Meyers Kenneth FDirector0Sep 28, 20230
Zulueta Alfonso GDirector0Sep 28, 20230
Monaghan Matthew E.Director0Sep 28, 20230
Dineen John M.Director0Sep 28, 20230
Connaughton BernadetteDirector0Sep 28, 20230
Olefson JonathanGeneral Counsel & Corp Secty0Sep 28, 20230
Bodem Barbara W.Director0Sep 28, 20230
Bonello Michael J.Chief Financial Officer0Sep 28, 20230
Keefe MichelleChief Executive Officer0Sep 28, 20230
Kralowetz Donna HildebrandEVP, Chief Accounting Officer0Sep 28, 20230
Wilkes David S.Director0Sep 28, 20230
Brooks Michael LeeChief Operating Officer0IndirectSep 28, 20230
Tucat ChristianChief Business Officer0Sep 28, 20230
Rudnick StanfordSee remarks31,013May 17, 20230
Meggs Jason M.Chief Financial Officer71,112Feb 24, 20230
Abbrecht Todd MDirector64,587May 27, 20220
Harty Linda SDirector8,006May 27, 20220
Macdonald AlistairChief Executive Officer228,131Mar 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2022 (view filing)Jul 281 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$78.00−$78.2K−2.1%47.6K after
Jul 29, 2022 (view filing)Jul 281 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$78.00−$39.0K−5.1%9.34K after
Jul 22, 2022 (view filing)Jul 211 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$76.00−$76.2K−2.0%48.6K after
Jul 22, 2022 (view filing)Jul 211 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$76.00−$38.0K−4.8%9.84K after
Jul 21, 2022 (view filing)Jul 201 dayOlefson JonathanGeneral Counsel & Corp SectySSaleClass A Common Stock−2.21K$75.00−$166.1K−8.1%25.3K after
Jul 20, 2022 (view filing)Jul 191 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−1.00K$74.00−$74.1K−2.0%49.6K after
Jul 20, 2022 (view filing)Jul 191 dayBrooks Michael LeeChief Operating OfficerSSaleClass A Common Stock−500$74.00−$37.0K−4.6%10.3K after
Jul 20, 2022 (view filing)Jul 182 daysKeefe MichelleChief Executive OfficerSSaleClass A Common Stock−8.33K$72.81−$606.7K−10.5%71.3K after
Jul 20, 2022 (view filing)Jul 182 daysMeggs Jason M.Chief Financial OfficerSSaleClass A Common Stock−7.50K$72.81−$546.1K−12.1%54.7K after
Jul 11, 2022 (view filing)Jul 83 daysKralowetz Donna HildebrandEVP, Chief Accounting OfficerSSaleClass A Common Stock−1.15K$73.16−$84.1K−14.4%6.80K after
Jun 2, 2022 (view filing)May 312 daysMonaghan Matthew E.DirectorSSaleClass A Common Stock−200$74.35−$14.9K−1.0%19.8K after
Feb 2, 2022 (view filing)Jan 312 daysKralowetz Donna HildebrandSVP, Chief Accounting OfficerSSaleClass A Common Stock−1.05K$90.00−$95.0K−13.6%6.68K after
Jan 3, 2022 (view filing)Dec 30, 20214 daysBrooks Michael LeeSee remarksSSaleClass A Common Stock−93$103.00−$9.58K−1.1%8.74K after
Dec 27, 2021 (view filing)Dec 234 daysOlefson JonathanGeneral Counsel & Corp SectySSaleClass A Common Stock−1.89K$100.95−$190.7K−8.3%20.8K after
Dec 23, 2021 (view filing)Dec 221 dayBrooks Michael LeeSee remarksSSaleClass A Common Stock−93$99.00−$9.21K−1.0%8.83K after
Dec 21, 2021 (view filing)Dec 201 dayHarty Linda SDirectorSSaleClass A Common Stock−4.12K$97.02−$399.9K−44.4%5.17K after
Sep 8, 2021 (view filing)Sep 35 daysKralowetz Donna HildebrandSVP, Chief Accounting OfficerSSaleClass A Common Stock−248$94.30−$23.4K−3.7%6.47K after
Sep 3, 2021 (view filing)Sep 3Same dayMeggs Jason M.Chief Financial OfficerSSaleClass A Common Stock−9.22K$95.00−$876.2K−15.2%51.5K after
Aug 4, 2021 (view filing)Aug 2-32 daysMacdonald AlistairChief Executive OfficerSSaleClass A Common Stock−40.3K$88.19−$3.55M−17.1%195.8K after3 lots
Jul 19, 2021 (view filing)Jul 163 daysMonaghan Matthew E.DirectorSSaleClass A Common Stock−170$88.64−$15.1K−1.0%17.1K after
Jul 7, 2021 (view filing)Jul 61 dayMeggs Jason M.Chief Financial OfficerSSaleClass A Common Stock−660$90.00−$59.4K−1.1%60.7K after2 lots
Jul 2, 2021 (view filing)Jun 302 daysMeggs Jason M.Chief Financial OfficerSSaleClass A Common Stock−4.67K$90.00−$420.1K−7.1%60.7K after2 lots